中文

泰克生物-酵母展示服务专家

Anti-C1S重组抗体|科研级 Sutimlimab ( 苏替莫单抗 )

询价与订购

  • 姓名*

  • 电话号码*

  • 电子邮件*

  • 产品名称*

  • 描述*

Anti-C1S重组抗体|科研级 Sutimlimab ( 苏替莫单抗 )
  • 详细相关信息
  • 靶点背景信息
  • 实验方案&FAQ
  • 相关产品
  • 推荐服务
  • 详细相关信息

    Catalog Number

    TKYR1498

    Alias

    科研级 Sutimlimab ( 苏替莫单抗 ), Anti-C1S Recombinant Antibody, Research Grade Sutimlimab

    Molecular Name

    Sutimlimab

    Size

    1mg, 5mg

    CAS Number

    2049079-64-1

    Isotype

    IgG4 Kappa

    Clonality

    Monoclonal

    Concentration

    1mg/ml

    Source

    CHO Cells

    Purity

    ≥95% as determined by SDS-PAGE

    Buffer

    Supplied in PBS, PH7.5

    Target

    C1S[Homo sapiens]

    Background

    Sutimlimab (INN, development code BIVV009) is a monoclonal antibody that is being investigated for cold agglutinin disease. This drug is being developed by Bioverativ, a Sanofi Company. As of 2018, sutimlimab is undergoing Phase III trials.

    Storage

    该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。

    NOTE

    仅科研使用
    靶点背景信息
    实验方案&FAQ

    体验泰克生物-酵母展示服务专家的可靠服务,请订阅: